by U.S. Medicine
While discontinuing chronic opioid therapy in veterans appears to be associated with decreased diagnoses for opioid-related adverse outcomes, the association with substance use disorders appears to be inconclusive, according to a new study.
by Annette Boyle
From 2010 to 2016, the number of veterans living on the streets dropped by half and the ending veteran homelessness within a decade appeared feasible.
by Guest Submission
A bill that would require the U.S. Department of Veterans Affairs to run clinical trials on the potential benefits of cannabis for the treatment of military veterans suffering from post-traumatic stress disorder and chronic pain was again rejected by the VA, even though the legislation—S.1467 VA Medicinal Cannabis Research Act of 2021—is supported by a plethora of veterans groups.
by Annette Boyle
Drug overdose deaths rocketed to previously unseen levels as the COVID-19 pandemic gripped the United States through 2020, and veterans weren’t spared.
by Stephen Spotswood
From 2012 to 2020, VA reduced prescription opioid use in patients in its healthcare system by 64%—from 679,000 veterans to 247,000.